INTRODUCTION
Cypher is a member of the PDZ -LIM domain family and directly complexes with Z-line-associated proteins, such as a-actinin-2 (1 -5), thus playing a critical role in muscle ultrastructure and function by maintaining Z-line integrity during muscle contraction in multiple species including mouse, zebrafish and Drosophila (3, (6) (7) (8) (9) . The functional importance of Cypher is evidenced by the phenotype of global Cypher-null mice, which are postnatal lethal with severe defects in striated muscle, including a congenital form of dilated cardiomyopathy (10) . In addition to its developmental roles, Cypher also plays a critical role in the adult heart, as cardiac-specific deletion in mice causes a severe form of dilated cardiomyopathy resulting in premature adult lethality (11) . Importantly, .15 mutations of ZASP, the human Cypher ortholog, have been identified in patients with cardiomyopathies including dilated cardiomyopathy and skeletal muscle myopathies (specifically termed zaspopathy) (7, (12) (13) (14) (15) (16) (17) (18) (19) (20) . However, the underlying molecular basis as to how deficiencies in Cypher lead to striated muscle diseases has not yet been fully understood.
We have previously shown that Cypher exists as six alternatively spliced isoforms that can be characterized as cardiac or skeletal muscle specific (21) . Cardiac and skeletal muscle each contain two long isoforms, which have three C-terminal LIM domains and may have a signaling role in addition to a structural role at the Z-line, and one short isoform without † The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors. * To whom correspondence should be addressed. Tel: +1 8588224276; Fax: +1 8588221355; Email: juchen@ucsd.edu # The Author 2011. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com LIM domains, which is primarily localized to the Z-line (21) . Similarly, human ZASP exists as six alternatively spliced isoforms, analogous to those in mouse striated muscle (13) . Expression of both long and short Cypher isoforms is tightly regulated during muscle development (21) . For example, Cypher short (CypherS) isoforms (2c, 2s) are barely detectable during embryogenesis but are strikingly induced postnatally in both cardiac and skeletal muscles (21) . In contrast, Cypher long (CypherL) isoforms (1c, 1s, 3c, 3s) exhibit consistent expression patterns from embryonic stages to adulthood (21) . Functionally unique roles for CypherS isoforms in muscle disease have also been suggested by specific early loss of CypherS isoforms along with calsarcin-1 in enigma homolog (ENH)-null hearts, which exhibit dilated cardiomyopathy (22) . These studies suggest that short and long Cypher isoforms could have both overlapping and unique roles in muscle development and disease.
In humans, a ZASP mutation (R268C) that affects only short isoforms is associated with skeletal myopathies (18) , while ZASP mutations (I352M, D626N, T350I D366N, Y468S, Q519P, P615L) that affect only long isoforms are primarily associated with cardiomyopathies, some of which affect specific signaling pathways such as protein kinase C (PKC) (7, 12, 13, 23, 24) . These findings indicate that isoformspecific mutations in ZASP may result in distinct etiologies of muscle disease; however, the underlying molecular and signaling mechanisms remain unclear.
By generating two novel CypherS and CyperL isoformspecific knockout mouse models, we sought to further determine isoform-specific roles of Cypher in striated muscle function and disease. Our present studies demonstrated that CypherS isoform knockout (CypherS KO) mice developed no detectable phenotypic abnormalities in muscle. In contrast, CypherL isoform knockout (CypherL KO) mice displayed partial neonatal lethality. Surviving CypherL KO mice exhibited growth retardation and late-onset dilated cardiomyopathy associated with early and selective defects in Z-line ultrastructure, as well as signaling [increased calcineurin-NFAT and specific PKC (a, b and 1)] pathways. These studies identify unique roles for CypherL isoforms in Z-line ultrastructure and in signaling that are distinct from the roles for CypherS isoforms. Additionally, our data provide insights into mechanisms by which mutations in CypherL isoforms are causative in muscle diseases, such as dilated cardiomyopathy.
RESULTS

Generation of CypherS and CypherL isoform-specific knockout mice
To investigate the specific role of CypherS and CypherL isoforms in regulating striated muscle function and disease, both CypherS (Cypher 2c, 2s) and CypherL (Cypher 1c, 3c, 1s and 3s) isoform-specific knockout mouse lines were generated by floxing exons 10 and 12 of the cypher gene, respectively ( Fig. 1A and D) , based on our previous studies (21) . Southern blot analyses of DNA isolated from G418-resistant embryonic stem (ES) cells identified wild-type (WT) (+/+) as well as targeted CypherS (f/+) and CypherL (f/+) floxed alleles ( Fig. 1B  and E) . Western blot analysis demonstrated that deletion of exons 10 and 12 successfully targeted the deletion of CypherS and CypherL isoforms, respectively, in CypherS and CypherL KO mouse hearts ( Fig. 1C and F) . However, loss of one Cypher isoform reciprocally affects the expression of the other Cypher isoform as evidenced by the increased expression of CypherL and CypherS isoforms in CypherS and CypherL KO mouse hearts, respectively ( Fig. 1C and F) .
Early postnatal growth retardation and late-onset dilated cardiomyopathy in CypherL but not CypherS KO mice CypherS and CypherL KO mice were born at expected Mendelian ratios; however, only 72% of CypherL KO mice survived until the age of 3 weeks (Table 1) , with most of the mortality observed within the first week after birth ( Fig. 2A) . Analysis of surviving CypherL KO mice during the first 3 weeks after birth revealed that these mice displayed dramatic growth retardation when compared with WT littermates, as reflected by significantly smaller body size ( Fig. 2B ) and lower body weight (Fig. 2C ). Growth defects observed in CypherL KO mice gradually lessened with age and allowed these mice to reach body weights similar to those of WT littermates by 3 months of age (Fig. 2D) . However, CypherL KO mice subsequently displayed a premature adult mortality, beginning at 16 months, with none surviving past 20 months of age ( Fig. 2A) . Serial echocardiographic assessment of CypherL KO mouse hearts revealed late-onset cardiomyopathy, beginning at 9 months, which was suggestive of dilated cardiomyopathy. CypherL KO mouse hearts were characterized by significant increases in chamber size [increased left ventricular internal dimensions at end-diastole (LVIDd)] at 9 months of age and significant chamber wall thinning [decreased left ventricular posterior wall thickness at end-diastole (LVPWd)], which reached statistical significance at 16 months (a time point when sudden death was observed) when compared with WT littermate hearts ( Fig. 2E and F) . The heart weight to body weight (HW/BW) ratio of CypherL KO mouse hearts was also significantly increased at 9 months when compared with WT controls (Fig. 2G ). Fractional shortening (FS), an index of left ventricle systolic function, also progressively and significantly decreased with age in CypherL KO mice, reaching lows of 20% by 16 months (Fig. 2H ). When compared with WT littermates, no significant differences in cardiac dimensions and function could be observed in CypherL KO hearts at 5 months of age ( Fig. 2E -G) . It should also be noted that CypherS KO mice did not display any differences in cardiac dimensions and function up to 2 years of age when compared with WT controls, when assessed by echocardiography (Supplementary Material, Fig. S1 ).
Histological assessment of CypherL KO hearts revealed left and right ventricular chamber enlargement at 9 months when compared with WT controls, which was not apparent at 5 months (Fig. 3A) , which is consistent with our findings using echocardiography (Fig. 2E -G) . CypherL KO hearts exhibited severe fibrosis (Fig. 3B) and calcification ( Fig. 3C ) at 5 months, the latter of which could be readily visualized by aberrant densities of brightness using echocardiography. Echocardiography revealed that 38% of CypherL KO hearts displayed calcification (data not shown). CypherL KO Fig. S3 ). Chronic isoproterenol stimulation of young CypherL KO mice also led to significant and aberrant increases in the LV/BW (left ventricle weight/body weight) ratio ( Fig. 4D ), when compared with WT mice, further demonstrating an increased susceptibility of CypherL KO mice to adverse changes in cardiac dimensions and function. The ratio of heart weight to body weight (HW/BW) (mg/g) was larger in CypherL KO mice (n ¼ 8) than in WT controls (n ¼ 7) at 9 months. (H) CypherL KO mice displayed dramatically reduced heart function as shown by FS% beginning at 9 months progressing in severity until the age of 16 months ( * P , 0.05).
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Inotropic and lusitropic dysfunction precedes dilated cardiomyopathy in CypherL KO mice
To further explore contractile defects in CypherL KO hearts, we subjected 5-month-old WT and CypherL KO mice to cardiac hemodynamic evaluation at rest and following stepped increases in dobutamine (b-adrenergic) stimulation. Heart rates and left ventricle peak systolic pressure (either at baseline or when stimulated with various doses of dobutamine) were not significantly different between CypherL KO and WT mice ( Fig. 5A and B) . However, when stimulated with 4 mg/kg/min of dobutamine, CypherL KO mice exhibited significant contractile dysfunction as evidenced by a decreased maximum positive derivative of LV pressure as measured over time (Max dP/dt) (Fig. 5C) . Furthermore, the minimum positive derivative of LV pressure as measured over time (Min dP/dt, at baseline and when stimulated with various concentrations of dobutamine) was significantly reduced in CypherL KO mice, when compared with WT mice (Fig. 5D) . Additionally, the calculated tau values, using a linear regression fit of the relation between dP/dt and pressure during isovolumic pressure decline, were significantly longer in CypherL KO than in WT mice (Fig. 5E ). Altogether, these data indicate that CypherL KO mice developed early inotropic and lusitropic dysfunction at 5 months of age before the onset of histological/functional defects associated with dilated cardiomyopathy. In contrast, CypherS KO mice demonstrated no differences in systolic or diastolic function at 2 years of age either at basal conditions or under various concentrations of dobutamine stimulation, when compared with WT littermate mice (Supplementary Material, Fig. S4 ).
CypherL but not CypherS KO mice display underlying cardiac muscle Z-line abnormalities
Since Cypher directly localizes to the Z-line (10,11), we performed transmission electron microscopy (TEM) to examine the ultrastructure of the Z-line in left ventricular cardiomyocytes of young CypherL KO mice at 3 months of age (Fig. 6 ). We demonstrate that CypherL KO cardiomyocytes displayed dramatically wider Z-lines (473.1 + 132.7 versus 84.9 + 9.1 nm; P ≤ 0.001; CypherL KO versus WT, respectively), which were also disorganized ( Fig. 6A -C) when compared with WT cardiomyocytes. M-line structure was lost in areas where there was severe disruption in cardiac muscle Z-line architecture in CypherL KO hearts (Fig. 6B) . Interestingly, we could also identify regions in CyperL KO hearts with intact Z-line integrity and organized sarcomeric structure as seen in WT cardiac muscle (data not shown), suggesting a level of heterogeneity in Z-line ultrastructural defects at this age. Sarcomere lengths in cardiac muscles of CypherL KO mice were comparable with those of WT controls (data not shown). No detectable defects in cardiac sarcomeric ultrastructure were observed in CypherS KO hearts at this age, when compared with WT littermate hearts (Supplementary Material, Fig. S5 ).
CypherL KO hearts display aberrant expression of specific protein complexes associated with Z-line ultrastructure and signaling
To determine the influence of CypherL isoform ablation on the expression of other Z-line-associated proteins, we assessed expression levels of proteins thought to either directly (myotilin, calsarcin-1, PKC, a-actinin-2, ENH) or indirectly (desmin, aB-crystallin, calcineurin) bind to Cypher at the Z-line, in relatively young CypherL KO hearts, prior to the dilated phenotype. Overall, no significant differences in cytoskeletal proteins, a-actinin and desmin, were observed in CypherL KO hearts when compared with controls (Fig. 7A) . However, a significant upregulation in Z-line-associated proteins, myotilin and aB-crystallin, was seen in CypherL KO hearts (Fig. 7A) . As previously demonstrated, a compensatory increase of CypherS isoforms was observed in CypherL KO hearts. CypherS isoforms are thought to directly interact/ form a complex with ENH and calsarcin-1 at the Z-line (22); however, no significant differences in ENH isoforms or calsarcin-1 were observed in CypherL KO hearts when compared with WT controls (Fig. 7A) . Interestingly, a significant increase in the activity of the calsarcin-1-interacting protein, calcineurin, was observed in CypherL KO hearts prior to the dilated phenotype. This was evidenced by an increase in nuclear translocation of NFATc4 ( Fig. 7B and C) , a substrate of calcineurin, as well as an increase in mRNA and protein levels of MCIP, a downstream target of NFAT, in CypherL KO hearts, when compared with WT controls (Fig. 7D and E) . CypherL, but not CypherS, isoforms also directly bind to various PKC isoforms through their C-terminal LIM domains (1). We found that expression of PKCa, b and 1 but not PKCd was significantly upregulated in CypherL KO hearts when compared with WT controls (Fig. 8A and B Material, Fig. S6 ). To determine the specificity of signaling pathways affected via ablation of Cypher isoforms, we assessed the expression of several other growth-related signaling pathways in CypherL KO hearts. Similar to our previous report of the cardiac-specific deletion of Cypher, we found no detectable changes in the activation of Akt in CypherL KO mouse hearts when compared with WT controls Human Molecular Genetics, 2011, Vol. 20, No. 9 1757 (Fig. 8C) . In contrast to the Cypher cardiac-specific KO hearts, neither Erk1/2 nor P38 mitogen-activated protein kinase (MAPK) phosphorylation was significantly altered in 3-month-old CypherL KO mouse hearts when compared with WT controls (Fig. 8C) , further demonstrating the specificity of Z-line protein signaling complexes affected by ablation of CypherL isoforms. We also found that filamin C, which connects to the Z-line via myotilin and calsarcin and to the membrane via the dystrophin -glycoprotein complex, and bID integrin were significantly upregulated in CypherL KO hearts. In addition, various components of the dystrophin -glycoprotein complex, including syntrophin and g-sarcoglycan, were also upregulated in CypherL KO hearts (Fig. 8D) prior to the onset of dilated cardiomyopathy. In CypherS KO mouse hearts, with the exception of myotilin and dystrophin, whose expression was slightly increased, all other Z-line-associated proteins and members of the dytrophin -glycoprotein complex were unaltered (Supplementary Material, Fig. S6 ), highlighting a specific connection between CypherL/Z-line and the sarcolemma -sarcoglycan complex.
DISCUSSION
Cypher is known to interact with multiple protein complexes at the Z-line, including a-actinin, myotilin, calsarcin-1 and PKC (1, 11, 25) . However, specific interactions of individual Cypher isoforms with distinct Z-line protein signaling complexes, and the relevance of these interactions to human disease remain unclear. Utilizing isoform-specific Cypherdeficient mice, we provide direct evidence for a unique role for CypherL isoforms in cardiac Z-line protein signaling/structural complexes which is critical for Z-line ultrastructural integrity. Loss of CypherL isoforms leads to late-onset dilated cardiomyopathy. We also define two developmental stages where CypherL but not short isoforms are essential for survival, as evidenced by the significant postnatal lethality exhibited by 28% of CypherL KO mice, similar to conventional Cypher-null mice in which all Cypher isoforms are ablated (10) , and the adult lethality caused by late-onset dilated cardiomyopathy exhibited in CypherL KO mice, similar to cardiacspecific Cypher KO mice (11) . Despite upregulated expression of CypherS in CypherL KO mice, these mice develop late-onset dilated cardiomyopathy with fibrosis and calcification, as well as early susceptibility to cardiomyopathy following biomechanical stress.
Our studies suggest that CypherS isoforms are dispensable for mouse survival, cardiac muscle development and the response to cardiac stress. However, in contrast to global knockout mice in which all Cypher isoforms are ablated and where all mice die within the first week after birth (10), some CypherL mutants survive until adulthood, suggesting some degree of functional overlap between CypherL and CypherS isoforms. This is consistent with our previous studies, which demonstrated that either long or short Cypher 
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Whether genetic background plays a role in the observed partial neonatal lethality and late-onset cardiomyopathy of CypherL mutants has yet to be determined. Cypher plays an important role in the integrity of Z-line ultrastructure (10, 11) . However, the role of specific Cypher isoforms in maintaining Z-line structural integrity remains unclear. The current studies have demonstrated that CypherL but not CypherS KO hearts display widened and disorganized Z-lines in adult cardiac muscle, which suggests that the short isoforms do not play a structural role in maintaining Z-line integrity, or that the short isoforms in CypherL KO hearts are not sufficient to maintain intact Z-lines in cardiac muscle. CypherL and CypherS isoforms contain a common PDZ domain, which recognizes the C-terminus of a-actinin-2, calsarcin-1 and myotilin, and a ZM motif that recognizes the rod-domain of a-actinin-2 (1, 11, 25, 26) . Our results suggest that interactions between Cypher and a-actinin-2 may not be sufficient to maintain the integrity of the Z-line. Since only CypherL KO hearts displayed disorganized Z-line structures, our studies further suggest that there remain novel interactions between CypherL and potentially the unique Cypher LIM domains and other Z-line proteins that are critical to maintenance of Z-line integrity.
Cypher can interact with a number of Z-line-associated proteins; however, the relevant Z-line-associated protein interactions underlying Z-line defects observed in CypherL KO mice remain unclear. We showed, through protein analyses, that young CypherL KO hearts displayed specific increases in two major Z-line-associated protein signaling complexes, highlighting CypherL isoforms as a nodal point for Z-line signaling. The calcineurin -NFAT pathway was aberrantly activated in young CypherL KO hearts, as evidenced by increased NFATc4 nuclear translocation and expression of MCIP, a downstream target of NFAT (27, 28) , in CypherL but not CypherS KO hearts, prior to the onset of the dilated phenotype. Calcineurin is a phosphatase that can interact with calsarcin-1 at the Z-line (29) (30) (31) and is thought to play an important role in cardiac hypertrophy and dilated cardiomyopathy (32 -35) . We and others have also shown that Cypher can interact with calsarcin-1 through its PDZ domain (11, 25) , identifying a Cypher/calsarcin-1/calcineurin complex that could be critical in maintaining Z-line integrity/signaling and contributing to the pathogenesis of dilated cardiomyopathy. Although our studies suggest that Cypher may negatively regulate calcineurin activity within this complex, our data clearly demonstrate that the observed effects on calcineurin activity are independent of alterations to calsarcin-1, since loss of CypherL isoforms does not alter levels of calsarcin-1 in CypherL KO hearts.
Our studies also reveal that PKCa, b and 1 signaling pathways are aberrantly and selectively activated in CypherL but not CypherS KO mouse hearts, prior to the onset of the dilated phenotype. We have previously demonstrated that the long isoforms of Cypher directly interact with PKC isoforms (a, b, z, g, d and 1) via their LIM domains, and can be phosphorylated by PKCs (1). Accumulating evidence suggests that PKC signaling plays a critical role in the development of cardiac hypertrophy (36) (37) (38) . In vivo models of pressure overload hypertrophy and human heart failure are associated with increased activity of a number of PKC isoforms (39) (40) (41) . In addition, overexpression of PKCbII in mouse heart results in hypertrophy and cardiomyopathy (42) , while overexpression of PKC1 results in the development of dilated cardiomyopathy with heart failure (43, 44) . Studies in human patients with Cypher/ZASP mutations identified a particular gain-of-function mutation within the Cypher/ZASP third LIM domain (D626N) that is causative for dilated cardiomyopathy and enhances the affinity of PKC for Cypher/ZASP (12) . The current studies suggest the possibility that CypherL isoforms (and LIM domains) uniquely act to negatively regulate PKC signaling in the normal heart.
Our studies further highlight Z-line protective mechanisms essential for optimal force generation and transmission, which are activated within the CypherL KO heart, prior to the onset of dilated cardiomyopathy. We specifically demonstrate upregulation of aB-crystallin, a stress protein associated with Z-lines, as well as increases in myotilin, filamin C and components of the integrin/dystrophin -glycoprotein complex in CypherL KO hearts, prior to the onset of the dilated phenotype. These alterations are likely to result in compensatory increased connections between sarcomeres and the extracellular matrix, suggestive of Z-line protection. Since increased myotilin and dystrophin were also observed in CypherS KO hearts, our studies have identified both unique and overlapping molecular pathways consequent to the mutations of distinct Cypher isoforms, some of which are important for susceptibility to cardiomyopathy.
In conclusion, the present study has demonstrated unique and essential roles for CypherL isoforms in survival as well as its roles in Z-line ultrastructure, signaling [e.g. calcineurin -NFAT and PKC (a, b and 1) pathways] and function in adult cardiac muscle, which are different from those of CypherS isoforms. Our studies provide mechanistic insight into mechanisms by which mutations in CypherL isoforms result in muscle diseases, such as dilated cardiomyopathy. We believe that these studies pave the way to a better understanding of Cypher isoforms in striated muscle function in vivo, which could also be of critical importance in screening and treating different types of muscle pathologies.
MATERIALS AND METHODS
Generation of two Cypher isoform-specific KO mouse models
Genomic DNA fragments specific for cypher short (exon 10) or long (exon 12) isoforms were amplified from mouse ES cells (129/SvJ) using polymerase chain reaction (PCR) and used to construct both CypherS and CypherL targeting constructs, as previously described (Fig. 1) (45) . For the CypherS construct, one LoxP site was inserted into intron 9 and a second LoxP site together with a neomycin cassette flanked by FRT sites was inserted into intron 10. For the CypherL construct, the first LoxP site was inserted into intron 11 and the second LoxP site with a neomycin cassette was inserted into intron 13. Both targeting vectors were linearized with the restriction enzyme NotI and electroporated into R1 ES cells derived from 129/SvJ mice (UCSD Transgenic and Gene Targeting Core, La Jolla, CA, USA). Homologous recombinants of both constructs were identified by Sothern blotting. Genomic DNA from G418-resistant ES cell clones was digested with the restriction enzyme EcoRI and hybridized with the radiolabeled 453-bp 5
′ -probes as indicated in Figure 1 . The WT allele is represented as a 17.1 kb band, whereas a 4.2 kb band represents the targeted allele. All fragments generated by PCR using high-fidelity KOD Hot Start DNA polymerase (Novagen, Gibbstown, CA, USA) were cloned into the PCR-Blunt II-TOPO vector (Invitrogen, Carlsbad, CA, USA), and sequences were verified.
Two independent homologous recombinant clones for either the CypherS or CypherL constructs were microinjected into C57BL/6 blastocysts. ′ and P6 5 ′ -TCCAGCT AGGACTATCTGTTTCCT-3 ′ ). All procedures described in this manuscript were completed using mice of a mixed 129/ SvJ and Black Swiss background.
All procedures were performed in accordance with the NIH Guide for the Care and Use of Laboratory Animals and approved by the Institutional Animal Care and Use Committee of UCSD.
Echocardiography and hemodynamic measurement
Adult mice were anesthetized with 1% isoflurane and subjected to echocardiography as previously described (22) . Adult mice were anesthetized using 100 mg/kg ketamine and 5 mg/kg xylazine and subjected to hemodynamic measurement as described previously (22) .
RNA analysis
Total RNA was isolated from mouse ventricles using Trizol reagent (Invitrogen) following the manufacturer's protocol. RNA dot-blot and real-time PCR were performed as previously described (22) . Quantitation of RNA levels from the dot-blot result was performed using ImageJ software. The oligonucleotide primers for MCIP used for real-time PCR were as follows: forward: 5 ′ -TCCAGCTTGGGCTTGACTGAG-3 ′ and reverse: 5 ′ -ACTGGAAGGTGGTGTCCTTGTC-3 ′ .
Transmission electron microscopy TEM was performed as described previously at the National Center for Microscopy and Imaging Research, University of California San Diego (22) .
Histological analysis
Hematoxylin and eosin (H&E) staining was performed on 7-mm sections according to standard procedures (10) . Trichrome staining was performed using the manufacturer's protocol (Sigma, St Louis, MO, USA). Calcification was detected by Von Kossa staining as previously described (48) .
Western blot analysis
Freshly isolated hearts were homogenized in RIPA buffer with protease inhibitor cocktail (Roche, Basel, Switzerland) and PhosSTOP (Roche). Protein concentration was determined by DC protein assay kit (BioRad, Hercules, CA, USA). Standard procedures were used for SDS -PAGE and subsequent transfer to PVDF membranes. Filamen-C, myotilin and bID integrin antibodies were gifts from Dr Louis M. Kunkel (Harvard Medical School, Boston, MA, USA), Dr Olli Carpen (University of Helsinki, Helsinki, Finland) and Dr Robert S. Ross (University of California San Diego, La Jolla, CA, USA), respectively. Commercial antibodies for a-actinin (Sigma-Aldrich, St Louis, MO, USA), calsarcin-1 (Alpha Diagnostic International, San Antonio, TX, USA), calcineurin (BD Biosciences, San Jose, CA, USA), desmin, syntrophin (Abcam, Cambridge, MA, USA), aB-crystallin (Stressgen, Ann Arbor, MI, USA), dystrophin (Spring Biosciences, Pleasanton, CA, USA) and g-sarcoglycan (Vector Laboratories, Burlingame, CA, USA) were used. MAPK, p-MAPK and AKT antibody sampler kits were purchased from Cell Signaling Technologies (Danvers, MA, USA). Antibodies for GAPDH and NFATc4 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibodies for PKCs were purchased from Cell Signaling Technologies (Danvers) and Santa Cruz. The ENH antibody was purchased from Novus Biologicals (Littleton, CO, USA).
Transverse aortic constriction banding and isoproterenol administration
Two-month-old male mice either underwent a sham operation or were subjected to pressure overload induced by thoracic aorta banding as previously described (22) . Echocardiography measurements were performed before surgery, 2 and 4 weeks post-TAC. Mice were sacrificed 4 weeks post-TAC. For chronic isoproterenol administration, mini-osmotic pumps (model 1007D, Alzet) containing isoproterenol or saline were inserted subcutaneously in the backs of 3-month-old male mice. The pumps delivered either 28 mg of isoproterenol per hour per 25 g of body weight in a 0.9% saline solution or saline alone as a negative control as previously described (49) . Mice were sacrificed 7 days later for the assessment of cardiac hypertrophy.
Statistics
All data are expressed as mean values + standard error of the mean. We performed statistical evaluation using Student's unpaired t-test. P , 0.05 was considered to be statistically significant.
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